Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      UAEs NMC Health makes two Gulf acquisitions worth 207 million dollars

      UAE's NMC Health makes two Gulf acquisitions worth 207 million dollars

      Ruby Khatun Khatun23 Jan 2018 9:30 AM IST
      ABU DHABI: NMC Health has made two acquisitions worth $207 million, the London-listed and United Arab Emirates-based healthcare provider said on...
      India loses 4 percent of GDP to malnutrition: ASSOCHAM-EY

      India loses 4 percent of GDP to malnutrition: ASSOCHAM-EY

      Ruby Khatun Khatun22 Jan 2018 11:00 AM IST
      New Delhi: As Finance Minister Arun Jaitley is busy giving final touches to the Union Budget for 2018-19, an ASSOCHAM-EY joint paper has said that...
      Sanofi to buy Bioverativ for 11.6 billion dollars

      Sanofi to buy Bioverativ for 11.6 billion dollars

      Ruby Khatun Khatun22 Jan 2018 10:45 AM IST
      PARIS: French healthcare group Sanofi has agreed to buy U.S. peer Bioverativ for $11.6 billion, in a deal which Sanofi said would boost its earnings...
      Increase budget allocation in healthcare: Lambda Life Sciences

      Increase budget allocation in healthcare: Lambda Life Sciences

      Ruby Khatun Khatun22 Jan 2018 10:30 AM IST
      New Delhi: Health tech start-up Lambda Life Sciences urged the government to provide investment support and increased allocation in the healthcare...
      Kite pharma collaborates with Pfizer to evaluate combination of Yescarta and Utomilumab

      Kite pharma collaborates with Pfizer to evaluate combination of Yescarta and Utomilumab

      Ruby Khatun Khatun22 Jan 2018 10:00 AM IST
      FOSTER CITY, Calif. & SANTA MONICA, Calif: Kite, a Gilead Company, announced it has entered into a clinical trial collaboration with Pfizer, Inc....
      Astrazeneca receives Japan approval for Lynparza to treat advanced ovarian cancer

      Astrazeneca receives Japan approval for Lynparza to treat advanced ovarian cancer

      Ruby Khatun Khatun22 Jan 2018 9:30 AM IST
      AstraZeneca and Merck & Co (known as MSD outside the US and Canada) announced that the Japanese Ministry of Health, Labour and Welfare has...
      Torrent Pharma acquires Bio-Pharm Inc

      Torrent Pharma acquires Bio-Pharm Inc

      Ruby Khatun Khatun21 Jan 2018 11:00 AM IST
      New Delhi: Drug firm Torrent Pharmaceuticals said it has acquired US-based generic pharmaceuticals and OTC firm Bio-Pharm Inc for an undisclosed...
      Need to strengthen medical insurance coverage, says industry

      Need to strengthen medical insurance coverage, says industry

      Ruby Khatun Khatun21 Jan 2018 10:45 AM IST
      New Delhi: There is an urgent need to strengthen medical insurance coverage in the country and develop talent in the healthcare sector, private...
      FDA plans more restrictive policy for bulk drug compounding

      FDA plans more restrictive policy for bulk drug compounding

      Ruby Khatun Khatun21 Jan 2018 10:30 AM IST
      The head of the U.S. Food and Drug Administration (FDA) said it is preparing a new, more restrictive policy targeting what drugs compounding...
      Merck, Cancer Research UK, Institute of Cancer Research collaborates on cancer drug discovery

      Merck, Cancer Research UK, Institute of Cancer Research collaborates on cancer drug discovery

      Ruby Khatun Khatun21 Jan 2018 10:15 AM IST
      Cancer Research UK’s Commercial Partnerships Team and The Institute of Cancer Research, London, announced a multi-project collaboration and licensing...
      Global digital health venture capital funding up 42 percent at 7.2 billion dollars

      Global digital health venture capital funding up 42 percent at 7.2 billion dollars

      Ruby Khatun Khatun21 Jan 2018 10:00 AM IST
      New Delhi: Venture capital (VC) funding, via private equity as well as corporate, jumped 42 percent to a record USD 7.2 billion in the digital health...
      Rakesh Jhunjhunwala, Premji vie to buy Star Health Insurance

      Rakesh Jhunjhunwala, Premji vie to buy Star Health Insurance

      Ruby Khatun Khatun21 Jan 2018 9:23 AM IST
      CHENNAI: Indian giants Rakesh Jhunjhunwala and Azim Premji seem to in the race to buy Star Health, according to recent media reportsStar Health and...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok